Age-related differences in adriamycin-induced nephropathy

Area of Science:

• Nephrology
• Toxicology
• Animal Models

Background:

• Adriamycin (doxorubicin hydrochloride) is a chemotherapy agent known to cause kidney damage (nephropathy).
• The impact of animal age on the severity of adriamycin-induced nephropathy is not fully understood.

Purpose of the Study:

• To investigate how age affects the development of adriamycin-induced nephropathy in mice.
• To explore the potential roles of decorin and fibromodulin in age-related differences in nephropathy severity.

Main Methods:

• Female Balb/C mice aged 5 and 12 weeks received a single intravenous injection of adriamycin (20 mg/kg).
• Urinary protein and transforming growth factor (TGF)-beta1 levels were measured.
• Glomerular sclerosis/hyalinosis and tubulointerstitial fibrosis were scored.
• Decorin and fibromodulin gene expression was quantified via reverse transcription-polymerase chain reaction.

Main Results:

• Older (12-week-old) mice showed significantly higher proteinuria, urinary TGF-beta1 excretion, and interstitial fibrosis compared to younger (5-week-old) mice.
• No significant age-related differences were observed in decorin and fibromodulin expression levels.
• Baseline urinary TGF-beta1 and gene expression of decorin and fibromodulin did not differ with age in normal mice.

Conclusions:

• Mice at 12 weeks of age develop more severe adriamycin-induced nephropathy than 5-week-old mice at equivalent weight-based doses.
• Decorin and fibromodulin do not appear to mediate the observed age-dependent differences in nephropathy severity.